UF startup Kriya Therapeutics, Inc., a clinical-stage biopharmaceutical company developing gene therapies to address common chronic diseases of high unmet need, announced multiple presentations at the upcoming American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting, which will be held May 11 to 15, 2026 in Boston, MA.
“Kriya is committed to overcoming key barriers to making gene therapies broadly accessible globally. We built our company from the beginning to ensure our therapies not only have transformative therapeutic potential but also serve the real world needs of patients affected by chronic diseases,” said Shankar Ramaswamy, M.D., Co-Founder and CEO of Kriya.
Read more about Kriya Announces Presentations at ASGCT 2026 Highlighting Advances Across Gene Therapy Platform.
